DF Dent & Co. Inc. cut its holdings in Steris Plc (NYSE:STE) by 2.5% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 909,766 shares of the medical equipment provider’s stock after selling 23,403 shares during the period. Steris Plc comprises approximately 2.0% of DF Dent & Co. Inc.’s holdings, making the stock its 24th biggest position. DF Dent & Co. Inc. owned 1.07% of Steris Plc worth $74,146,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. California State Teachers Retirement System acquired a new position in shares of Steris Plc in the 2nd quarter valued at about $12,573,000. Atlanta Capital Management Co. L L C boosted its holdings in shares of Steris Plc by 4.7% in the 2nd quarter. Atlanta Capital Management Co. L L C now owns 431,514 shares of the medical equipment provider’s stock valued at $35,169,000 after buying an additional 19,427 shares during the period. Coldstream Capital Management Inc. boosted its holdings in shares of Steris Plc by 7.0% in the 2nd quarter. Coldstream Capital Management Inc. now owns 9,337 shares of the medical equipment provider’s stock valued at $761,000 after buying an additional 612 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in shares of Steris Plc by 1.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 122,520 shares of the medical equipment provider’s stock valued at $9,986,000 after buying an additional 1,963 shares during the period. Finally, Cubist Systematic Strategies LLC boosted its holdings in shares of Steris Plc by 176.3% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 9,393 shares of the medical equipment provider’s stock valued at $766,000 after buying an additional 5,994 shares during the period. 93.33% of the stock is owned by institutional investors and hedge funds.
In related news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $85.69, for a total transaction of $856,900.00. Following the completion of the sale, the chief executive officer now owns 83,270 shares in the company, valued at approximately $7,135,406.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Mohsen Sohi sold 2,744 shares of the stock in a transaction dated Wednesday, August 9th. The stock was sold at an average price of $85.98, for a total transaction of $235,929.12. Following the sale, the director now owns 21,816 shares of the company’s stock, valued at approximately $1,875,739.68. The disclosure for this sale can be found here. Insiders have sold a total of 194,086 shares of company stock valued at $16,953,621 in the last quarter. 2.55% of the stock is currently owned by corporate insiders.
Steris Plc (NYSE:STE) last announced its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. The business had revenue of $608.00 million during the quarter, compared to analysts’ expectations of $597.66 million. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. The firm’s revenue for the quarter was down 4.8% on a year-over-year basis. During the same quarter last year, the company posted $0.79 EPS. On average, equities analysts expect that Steris Plc will post $4.06 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, September 28th. Investors of record on Tuesday, August 29th were given a dividend of $0.31 per share. The ex-dividend date of this dividend was Friday, August 25th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.38%. This is a boost from Steris Plc’s previous quarterly dividend of $0.28. Steris Plc’s dividend payout ratio (DPR) is 88.57%.
Several research analysts have recently commented on STE shares. Zacks Investment Research raised shares of Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 price target for the company in a report on Tuesday, July 11th. BidaskClub lowered shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Finally, Raymond James Financial, Inc. lifted their price target on shares of Steris Plc from $90.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, August 9th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $89.00.
About Steris Plc
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Plc (NYSE:STE).
What are top analysts saying about Steris Plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Steris Plc and related companies.